Vetnique Labs, a pet well being and wellness firm, has acquired Lintbells, recognized for its YuMOVE model of pet dietary supplements, from personal fairness investor Inflexion. The transaction, backed by Gryphon Traders, is anticipated to shut within the third quarter of 2024, with monetary phrases undisclosed.
YuMOVE, a joint mobility complement model within the UK. for canines and cats, additionally gives dietary supplements addressing digestive well being, anxiousness, dermatological and dental wants. Based twenty years in the past in Hertfordshire, UK, YuMOVE emphasizes scientifically supported dietary supplements for power well being circumstances and is an authorized B Company.
Vetnique Labs presents a variety of vet-founded, vet-formulated and vet-recommended pet merchandise, together with dietary supplements and topical options for digestive well being, allergy and dermatological assist and ear care. Identified for its Glandex complement, the highest answer for anal gland illness in North America, Vetnique and YuMOVE share a dedication to offering efficient, veterinary-endorsed dietary supplements via varied distribution channels, together with pet specialty stores, veterinary distributors and direct-to-consumer.
This acquisition can be designed to broaden Gryphon’s presence within the pet well being and wellness sector, complementing its funding in Heartland Veterinary Companions. Chris Slager, government chairman of the mixed firm, expressed enthusiasm for the merger. “We’re thrilled to unite these well-known manufacturers and develop our presence in two of the biggest pet complement markets on the planet, the U.S. and the U.Ok.,” he stated. “Our mixed portfolio drastically will increase our firm’s scale throughout the important thing areas of hip & joint and digestive and can permit us to deliver science-backed formulations, medical efficacy, and patented merchandise to shoppers worldwide.”
James Bascharon, DVM, founder and CEO of Vetnique, will oversee North America operations, whereas Fiona Hope will proceed as CEO of YuMOVE, managing operations within the UK, Europe and different areas. “Our imaginative and prescient with Gryphon has at all times been to create a world pet well being and wellness platform within the $3 billion complement market,” stated Dr. Bascharon. “We’re excited to construct on our monitor document of worthwhile progress and assist speed up YuMOVE’s merchandise in North America.”
Hope highlighted the potential of the partnership to comprehend international progress alternatives and leverage Gryphon’s sources and experience to additional their mission of enhancing pet high quality of life. “We look ahead to becoming a member of forces with Vetnique and collectively exploring alternatives to comprehend the worldwide potential of our complementary pet portfolio,” she stated.
